IDEXX LABORATORIES DANMARK ApS — Credit Rating and Financial Key Figures
CVR number: 26996279
Sundkrogsgade 21, 2100 København Ø
vivian-dorenbos@idexx.com
Income statement (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | 6 222.12 | 6 486.72 | 8 443.00 | 9 539.84 | 8 006.81 |
| Employee benefit expenses | -4 844.09 | -5 086.90 | -6 734.58 | -7 513.73 | -6 207.11 |
| Total depreciation | -42.19 | -15.95 | -15.16 | -9.93 | -10.30 |
| EBIT | 1 335.85 | 1 383.87 | 1 693.26 | 2 016.17 | 1 789.39 |
| Other financial income | 0.61 | ||||
| Other financial expenses | -63.50 | -86.60 | -91.72 | -99.84 | 13.26 |
| Pre-tax profit | 1 272.96 | 1 297.27 | 1 601.54 | 1 916.33 | 16 237.94 |
| Income taxes | - 217.41 | - 136.93 | 1.13 | - 461.67 | 427.12 |
| Net earnings | 1 055.56 | 1 160.34 | 1 602.67 | 1 454.65 | 16 665.06 |
Assets (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Intangible assets total | |||||
| Machinery and equipment | 513.06 | 204.12 | 255.20 | 233.40 | 23.31 |
| Advance payments and construction in progress | 2 205.17 | 2 141.01 | |||
| Other tangible assets | -2 205.17 | -2 141.01 | |||
| Tangible assets total | 513.06 | 204.12 | 255.20 | 233.40 | 23.31 |
| Other non-current investments | 2 205.17 | 2 141.01 | |||
| Other receivables | 0.00 | ||||
| Investments total | 0.00 | 2 205.17 | 2 141.01 | ||
| Non-current other receivables | 819.26 | 1 544.51 | 1 752.28 | 123.89 | |
| Long term receivables total | 819.26 | 1 544.51 | 1 752.28 | 123.89 | |
| Inventories total | |||||
| Current trade debtors | 6 788.19 | 7 040.51 | 13 119.81 | 7 975.41 | 10 473.90 |
| Current amounts owed by group member comp. | 279.26 | 50.00 | 440.44 | ||
| Current owed by particip. interest comp. | 211.08 | ||||
| Prepayments and accrued income | 250.99 | 441.87 | 578.32 | 756.62 | 927.37 |
| Current other receivables | 0.00 | 82.42 | |||
| Current deferred tax assets | 24.09 | 129.88 | |||
| Short term receivables total | 7 318.45 | 7 693.47 | 13 748.13 | 8 756.12 | 12 054.01 |
| Cash and bank deposits | 9 549.95 | 12 973.04 | 11 595.85 | 10 857.27 | 13 687.68 |
| Cash and cash equivalents | 9 549.95 | 12 973.04 | 11 595.85 | 10 857.27 | 13 687.68 |
| Balance sheet total (assets) | 18 200.72 | 22 415.13 | 27 351.46 | 22 051.96 | 28 029.90 |
Equity and liabilities (kDKK)
2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Share capital | 125.00 | 125.00 | 125.00 | 125.00 | 125.00 |
| Other reserves | -15 289.52 | ||||
| Retained earnings | 10 016.30 | 11 071.86 | 12 232.20 | 13 834.87 | |
| Profit of the financial year | 1 055.56 | 1 160.34 | 1 602.67 | 1 454.65 | 16 665.06 |
| Shareholders equity total | 11 196.86 | 12 357.20 | 13 959.87 | 125.00 | 16 790.06 |
| Provisions | 79.71 | -0.00 | 15 289.52 | ||
| Non-current other liabilities | -0.00 | ||||
| Non-current deferred tax liabilities | 9.91 | ||||
| Non-current liabilities total | -0.00 | 9.91 | |||
| Current loans from credit institutions | 13 391.59 | ||||
| Current trade creditors | 520.25 | 396.13 | 360.55 | 591.99 | 535.76 |
| Current owed to participating | 5 999.85 | ||||
| Current owed to group member | 3 413.68 | 5 658.70 | 3 138.52 | 6 581.55 | |
| Short-term deferred tax liabilities | 113.42 | 53.34 | 97.14 | 417.71 | |
| Other non-interest bearing current liabilities | 2 366.40 | 3 608.61 | -10 083.34 | 2 565.73 | 3 305.60 |
| Accruals and deferred income | 510.40 | 3 966.94 | 341.20 | 389.32 | |
| Current liabilities total | 6 924.15 | 10 057.93 | 13 391.59 | 6 637.44 | 11 229.93 |
| Balance sheet total (liabilities) | 18 200.72 | 22 415.13 | 27 351.46 | 22 051.96 | 28 029.90 |
Try the full version of our system for free
Create your own estimates for any company
Valuation analysis
See instructions
... and more!
No registration needed.